Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05686265

Cerebral Nitrosative/Oxidative Stress in Aneurysmal Subarachnoid Haemorrhage

Conditions: Subarachnoid Hemorrhage, Aneurysmal

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: 1
Enrollment: 32
Sponsor: Rigshospitalet, Denmark

Location: Denmark

Summary

Aneurysmal subarachnoid haemorrhage (SAH) carries a high morbidity and mortality, which is in part due to the development of secondary brain injury. The mechanisms behind this remain incompletely understood, but oxidative/nitrosative stress and disturbances in vasoregulatory mechanisms are believed to be involved. The present study aims to characterise the transcerebral exchange of oxidative/nitrosative stress markers and nitric oxide metabolites during the early phase after SAH compared to healthy volunteers, including the influence of induced changes in arteriel oxygen tension.

Eligibility Criteria

Inclusion Criteria (patients):Age ≥ 18 yearsAdmission to the NICU at RigshospitaletDiagnosis of aneurysmal SAHNeed for sedation and mechanical ventilation after the aneurysm has been securedInitiation of study possible ≤3 days after the ictusClosest relatives understand written and spoken Danish or EnglishExclusion Criteria (patients):Brain death before inclusionExpected death within 24 hoursFailed or conservative treatment of the aneurysmSevere acute lung failure with a PaO2/FiO2-ratio ≤16 kPaSevere chronic lung failure with habitual long-term oxygen therapyHabitual treatment with medication directly affecting NO metabolism (e.g., sildenafil)Inclusion Criteria (patients):Age 40-60 years50/50 sex distribution (6 men and 6 women)Healthy (including no prior cerebrovascular disease)No regular medication or recreational drug useUnderstands written and spoken Danish or English

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05686265). StuddyBuddy aggregates publicly available trial information.